Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NAV2 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → NAV2 |
| (<<) ANKRD27 → NAV2 |
| (<<) DVL3 → NAV2 |
| (<<) EDN1 → NAV2 |
| (<<) EGFR → NAV2 |
| (<<) FAM46B → NAV2 |
| (<<) KHDRBS1 → NAV2 |
| (<<) KIAA1908 → NAV2 |
| (<<) KLK7 → NAV2 |
| (<<) KRT5 → NAV2 |
| (<<) MAP2K4 → NAV2 |
| (<<) NCOR2 → NAV2 |
| (<<) PLCB4 → NAV2 |
| (<<) PODXL → NAV2 |
| (<<) PPP1R12B → NAV2 |
| (<<) PPRC1 → NAV2 |
| (<<) SF3A2 → NAV2 |
| (<<) SFN → NAV2 |
| (<<) SULF2 → NAV2 |
| (<<) TCEB1 → NAV2 |
| (<<) TMEM39B → NAV2 |
| (<<) TSG101 → NAV2 |
| (<<) WASF2 → NAV2 |
| Downstream (Children) |
|---|
| NAV2 → PROCR (>>) |
| NAV2 → SMAD3 (>>) |
